162 related articles for article (PubMed ID: 34921102)
21. Longitudinal Associations Between Blood Biomarkers and White Matter MRI in Sport-Related Concussion: A Study of the NCAA-DoD CARE Consortium.
Wu YC; Wen Q; Thukral R; Yang HC; Gill JM; Gao S; Lane KA; Meier TB; Riggen LD; Harezlak J; Giza CC; Goldman J; Guskiewicz KM; Mihalik JP; LaConte SM; Duma SM; Broglio SP; Saykin AJ; McAllister TW; McCrea MA
Neurology; 2023 Jul; 101(2):e189-e201. PubMed ID: 37328299
[TBL] [Abstract][Full Text] [Related]
22. Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.
Mielke MM; Przybelski SA; Lesnick TG; Kern S; Zetterberg H; Blennow K; Knopman DS; Graff-Radford J; Petersen RC; Jack CR; Vemuri P
Alzheimers Dement; 2021 May; 17(5):801-812. PubMed ID: 33663022
[TBL] [Abstract][Full Text] [Related]
23. Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study.
Rise HH; Brune S; Chien C; Berge T; Bos SD; Andorrà M; Valdeolivas IP; Beyer MK; Sowa P; Scheel M; Brandt AU; Asseyer S; Blennow K; Pedersen ML; Zetterberg H; de Schotten MT; Cellerino M; Uccelli A; Paul F; Villoslada P; Harbo HF; Westlye LT; Høgestøl EA
Neuroimage Clin; 2022; 35():103099. PubMed ID: 35772194
[TBL] [Abstract][Full Text] [Related]
24. The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
Neurobiol Aging; 2021 Jan; 97():10-17. PubMed ID: 33070094
[TBL] [Abstract][Full Text] [Related]
25. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
26. Neurofilament relates to white matter microstructure in older adults.
Moore EE; Hohman TJ; Badami FS; Pechman KR; Osborn KE; Acosta LMY; Bell SP; Babicz MA; Gifford KA; Anderson AW; Goldstein LE; Blennow K; Zetterberg H; Jefferson AL
Neurobiol Aging; 2018 Oct; 70():233-241. PubMed ID: 30036759
[TBL] [Abstract][Full Text] [Related]
27. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
28. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
[TBL] [Abstract][Full Text] [Related]
29. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
[TBL] [Abstract][Full Text] [Related]
30. Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population-an analysis from the MEMO study.
Rübsamen N; Maceski A; Leppert D; Benkert P; Kuhle J; Wiendl H; Peters A; Karch A; Berger K
BMC Med; 2021 Feb; 19(1):38. PubMed ID: 33583409
[TBL] [Abstract][Full Text] [Related]
31. Serum neurofilament light chain, brain infarcts, and the risk of stroke: a prospective population-based cohort study.
Dhana A; DeCarli C; Aggarwal NT; Dhana K; Desai P; Evans DA; Rajan KB
Eur J Epidemiol; 2023 Apr; 38(4):427-434. PubMed ID: 36867286
[TBL] [Abstract][Full Text] [Related]
32. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C
Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
[TBL] [Abstract][Full Text] [Related]
33. Association of Neurofilament Light Chain, [
Palleis C; Franzmeier N; Weidinger E; Bernhardt AM; Katzdobler S; Wall S; Ferschmann C; Harris S; Schmitt J; Schuster S; Gnörich J; Finze A; Biechele G; Lindner S; Albert NL; Bartenstein P; Sabri O; Barthel H; Rupprecht R; Nuscher B; Stephens AW; Rauchmann BS; Perneczky R; Haass C; Brendel M; Levin J; Höglinger GU
Neurology; 2024 Jan; 102(1):e207901. PubMed ID: 38165362
[TBL] [Abstract][Full Text] [Related]
34. Findings of Vascular Brain Injury and Structural Loss from Cranial Magnetic Resonance Imaging in Elderly American Indians: The Strong Heart Study.
Suchy-Dicey AM; Shibata DK; Madhyastha TM; Grabowski TJ; Longstreth WT; Buchwald DS
Neuroepidemiology; 2017; 48(1-2):39-47. PubMed ID: 28259877
[TBL] [Abstract][Full Text] [Related]
35. Serum neurofilament light is sensitive to active cerebral small vessel disease.
Gattringer T; Pinter D; Enzinger C; Seifert-Held T; Kneihsl M; Fandler S; Pichler A; Barro C; Gröbke S; Voortman M; Pirpamer L; Hofer E; Ropele S; Schmidt R; Kuhle J; Fazekas F; Khalil M
Neurology; 2017 Nov; 89(20):2108-2114. PubMed ID: 29046363
[TBL] [Abstract][Full Text] [Related]
36. Association of covert brain infarcts and white matter hyperintensities with risk of hip fracture in older adults: the Cardiovascular Health Study.
Sheets KM; Buzkova P; Chen Z; Carbone LD; Cauley JA; Barzilay JI; Starks JL; Miller LM; Fink HA
Osteoporos Int; 2023 Jan; 34(1):91-99. PubMed ID: 36355067
[TBL] [Abstract][Full Text] [Related]
37. Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline.
Ebenau JL; Pelkmans W; Verberk IMW; Verfaillie SCJ; van den Bosch KA; van Leeuwenstijn M; Collij LE; Scheltens P; Prins ND; Barkhof F; van Berckel BNM; Teunissen CE; van der Flier WM
Neurology; 2022 Mar; 98(13):e1315-e1326. PubMed ID: 35110378
[TBL] [Abstract][Full Text] [Related]
38. Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuum.
Zhang M; Chen H; Huang W; Guo T; Ma G; Han Y; Shu N
Hum Brain Mapp; 2024 Jan; 45(1):e26566. PubMed ID: 38224535
[TBL] [Abstract][Full Text] [Related]
39. NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.
Ammitzbøll C; Dyrby TB; Börnsen L; Schreiber K; Ratzer R; Romme Christensen J; Iversen P; Magyari M; Lundell H; Jensen PEH; Sørensen PS; Siebner HR; Sellebjerg F
Mult Scler Relat Disord; 2023 Sep; 77():104854. PubMed ID: 37418931
[TBL] [Abstract][Full Text] [Related]
40. Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer's disease.
Yang Z; Sreenivasan K; Toledano Strom EN; Osse AML; Pasia LG; Cosme CG; Mugosa MRN; Chevalier EL; Ritter A; Miller JB; Cordes D; Cummings JL; Kinney JW
Alzheimers Res Ther; 2023 Nov; 15(1):190. PubMed ID: 37924152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
